Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPS6367659B2 - - Google Patents
[go: Go Back, main page]

JPS6367659B2 - - Google Patents

Info

Publication number
JPS6367659B2
JPS6367659B2 JP56043588A JP4358881A JPS6367659B2 JP S6367659 B2 JPS6367659 B2 JP S6367659B2 JP 56043588 A JP56043588 A JP 56043588A JP 4358881 A JP4358881 A JP 4358881A JP S6367659 B2 JPS6367659 B2 JP S6367659B2
Authority
JP
Japan
Prior art keywords
particles
serum
blood
fine particles
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56043588A
Other languages
Japanese (ja)
Other versions
JPS57159562A (en
Inventor
Seiichiro Honda
Hiroshi Ogawara
Yasumasa Kashima
Mutsumi Fukuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sekisui Chemical Co Ltd
Original Assignee
Sekisui Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sekisui Chemical Co Ltd filed Critical Sekisui Chemical Co Ltd
Priority to JP56043588A priority Critical patent/JPS57159562A/en
Publication of JPS57159562A publication Critical patent/JPS57159562A/en
Publication of JPS6367659B2 publication Critical patent/JPS6367659B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Centrifugal Separators (AREA)

Description

【発明の詳細な説明】 本発明は血清分離方法に関するものである。[Detailed description of the invention] The present invention relates to a serum separation method.

従来、採血用容器所謂合成樹脂製のスピツツ管
に採血した全血試料を血清と血餅とに分離するに
際して、これらの中間の比重を有する分離層形成
材料例えばポリスチレン小粒子或いはシリコーン
とシリカとからなるゲル状混合物の共存下で遠心
分離を行い、血清と血餅との間に上記材料からな
る分離層を形成せしめ、デカンテーシヨン等によ
つて目的の血清を採取する方法が提案されている
が、合成樹脂製のスピツツ管を用いる場合は血液
凝固に長時間要するという欠点があり、又、ポリ
スチレン小粒子を用いる場合、僅かの衝撃によつ
てポリスチレン小粒子からなる分離層が容易に破
壊され、デカンテーシヨンによるスピツツ管より
血清を採取する際に注意を要するという欠点があ
つた。一方、前記ゲル状混合物を用いる場合、ゲ
ル状混合物がチキソトロピー性を有するので、ス
ピツツ管内に該ゲル状混合物を分注する際の操作
が難しく作業能率が劣るという欠点があつた。
Conventionally, when separating a whole blood sample collected into a blood collection container, a so-called Spitz tube made of synthetic resin, into serum and blood clot, a separation layer-forming material having a specific gravity between these two, such as polystyrene small particles, silicone and silica, is used. A method has been proposed in which centrifugation is performed in the coexistence of a gel-like mixture of the above materials to form a separation layer made of the above materials between serum and blood clots, and the desired serum is collected by decantation or the like. However, when using a Spitz tube made of synthetic resin, blood coagulation takes a long time, and when using small polystyrene particles, the separation layer made of small polystyrene particles is easily destroyed by a slight impact. However, there was a drawback that caution was required when collecting serum from a Spitz tube by decantation. On the other hand, when using the above-mentioned gel-like mixture, since the gel-like mixture has thixotropic properties, there is a drawback that the operation when dispensing the gel-like mixture into a Spitz tube is difficult and the working efficiency is poor.

本発明は上述の欠点を解消するため鋭意研究し
た結果なされたものであり、血液凝固を著しく促
進すると共に血清と血餅との間に衝撃等に対して
極めて安定な分離層を形成し、極めて容易にしか
も高収率で血清を血液から分離する新規な方法を
提供することを目的とする。
The present invention was made as a result of intensive research to eliminate the above-mentioned drawbacks, and it significantly promotes blood coagulation and forms a separation layer between serum and blood clots that is extremely stable against impact, etc. It is an object of the present invention to provide a new method for easily separating serum from blood with high yield.

本発明の要旨は、容器内に採取された血液を遠
心分離によつて血清と血餅とに分離する方法にお
いて、(1)比重が1.03〜1.08、粒径が0.1〜5mmにし
て、25℃におけるボールタツク値が3〜7であ
り、アクリル酸エステルもしくはメタクリル酸エ
ステルのモノマーの単独又はこれらと共重合し得
るモノマーを重合して得られる、感圧粘着性を有
する微粒子1重量部と(2)粒径50〜500μのガラス
微粒子2〜10重量部とからなる混合物を容器内の
血液と共存させて遠心分離を行うことを特徴とす
る血清分離方法に存する。
The gist of the present invention is to provide a method for separating blood collected in a container into serum and blood clots by centrifugation. (2) 1 part by weight of fine particles having a ball tack value of 3 to 7 and having pressure-sensitive adhesive properties obtained by polymerizing an acrylic ester or methacrylic ester monomer alone or a monomer that can be copolymerized with these; The serum separation method is characterized in that a mixture consisting of 2 to 10 parts by weight of glass fine particles having a particle size of 50 to 500 microns coexists with blood in a container and then centrifuged.

本発明における感圧粘着性を有する微粒子と
は、加圧されると相互に粘着接合する性質を有す
る微粒子を指し、アクリル系の感圧粘着性微粒子
が用いられる。これら粘着性を有する微粒子の粒
径としては0.1〜5mmのものが用いられ、又粒径
がそろつているほど好ましい。又形状は、特に限
定されないが、球状のものが好ましい。上記粘着
性を有する微粒子の比重は1.03〜1.08の範囲に定
められるのであり、これは、上記微粒子の比重が
1.03未満であると、当該粘着性を有する微粒子が
血清の相中に浮遊し、又1.08を越えると、当該粘
着性を有する微粒子が血餅の相中に沈滞してしま
つて、二層間における分離層が形成できなくなる
という理由に基づく。
The fine particles having pressure-sensitive adhesive properties in the present invention refer to fine particles having the property of adhesively bonding to each other when pressurized, and acrylic pressure-sensitive adhesive fine particles are used. The particle size of these fine particles having adhesive properties is preferably 0.1 to 5 mm, and it is preferable that the particle sizes are uniform. Further, the shape is not particularly limited, but a spherical shape is preferable. The specific gravity of the above-mentioned adhesive particles is set in the range of 1.03 to 1.08, which means that the specific gravity of the above-mentioned particles is 1.03 to 1.08.
If it is less than 1.03, the sticky particles will float in the serum phase, and if it exceeds 1.08, the sticky particles will settle in the blood clot phase, causing separation between the two layers. This is based on the reason that layers cannot be formed.

尚、上記微粒子の比重調整のため、これら粘着
性を有する微粒子中にシリカ等の無機物を添加し
ても良い。
Incidentally, in order to adjust the specific gravity of the fine particles, an inorganic substance such as silica may be added to these sticky fine particles.

本発明における粘着性を有する微粒子を製造す
る方法としては、例えば2―エチルヘキシルアク
リレート、ブチルアクリレート等のアクリル酸エ
ステルモノマーの単独若しくはこれと共重合し得
るモノマーと混合して、油溶性の触媒の存在下
で、水中にて懸濁重合すれば、アクリル系の粘着
性を有する微粒子が得られる。又、上記重合の
際、安定剤としては、ポリビニルアルコールやポ
リアクリル酸の様な水溶性ポリマー、適当な界面
活性剤等、油溶性の触媒としては、ベンゾイルパ
ーオキサイド、メチルエチルケトンパーオキサイ
ド等の過酸化物やアゾビスイソブチロニトリル等
が用いられる。
In the present invention, the adhesive fine particles can be produced by mixing an acrylic acid ester monomer such as 2-ethylhexyl acrylate or butyl acrylate alone or with a monomer that can be copolymerized therewith in the presence of an oil-soluble catalyst. If suspension polymerization is carried out in water below, fine particles having acrylic adhesive properties will be obtained. In addition, during the above polymerization, stabilizers include water-soluble polymers such as polyvinyl alcohol and polyacrylic acid, suitable surfactants, etc., and oil-soluble catalysts include peroxides such as benzoyl peroxide and methyl ethyl ketone peroxide. or azobisisobutyronitrile, etc. are used.

上記モノマーとしては、特に炭素数が4〜10の
第1級若しくは第2級アルコールのアクリル酸エ
ステル若しくはメタクリル酸エステルを用いるの
が好ましい。又、これらのモノマーと共重合可能
なスチレン、メチルメタクリレート、アクリルア
ミド、アクリロニトリル等のモノマーを併用して
も良く、特に、ジビニルベンゼンやポリエチレン
グリコールジアクリレートの様な多官能性モノマ
ーを併用すれば、広い温度範囲に渡つて適度な微
粘着性を保持できる微粒子が得られる。この様に
して合成された粘着性を有する微粒子はよく水洗
して安定剤等の残留不純物を完全に除去した後、
乾燥して用いることが重要である。
As the above-mentioned monomer, it is particularly preferable to use an acrylic ester or methacrylic ester of a primary or secondary alcohol having 4 to 10 carbon atoms. In addition, monomers that can be copolymerized with these monomers such as styrene, methyl methacrylate, acrylamide, acrylonitrile, etc. may be used in combination, and in particular, if polyfunctional monomers such as divinylbenzene and polyethylene glycol diacrylate are used in combination, a wide range of possibilities can be obtained. Fine particles can be obtained that can maintain a moderate degree of tackiness over a temperature range. After the adhesive fine particles synthesized in this way are thoroughly washed with water to completely remove residual impurities such as stabilizers,
It is important to use it dry.

本発明における微粒子の有する粘着性の指標
は、粘着剤の分野で慣用のJ.Dowの方法による粘
着力を表わすボールタツク値が採用される。即
ち、測定しようとする粘着性を有する微粒子をエ
タノール等の有機溶剤に分散せしめ、ポリエステ
ル等のフイルム基体上に塗布し、乾燥させた後、
これを30度の傾斜を有する台の上に固定する。次
いで台の上部より各種大きさのステンレス球を該
球の大きい順からころがし、長さ10cmの粘着剤を
塗布した領域で停止しうるステンレス球の大きさ
でもつてボールタツク値を表わす。例えばX/32
インチ径のステンレス球を用いて上記条件を満た
した場合、ボールタツク値はXである。
As an index of the adhesiveness of the fine particles in the present invention, a ball tack value representing adhesive strength is used according to the method of J. Dow, which is commonly used in the field of adhesives. That is, fine particles having the tackiness to be measured are dispersed in an organic solvent such as ethanol, coated on a film substrate such as polyester, and dried.
This is fixed on a table with a slope of 30 degrees. Next, stainless steel balls of various sizes are rolled from the top of the table, starting from the largest ball, and the ball tack value is expressed as the size of the stainless steel ball that can stop in the adhesive-applied area with a length of 10 cm. For example, X/32
When the above conditions are satisfied using inch diameter stainless steel balls, the ball tack value is X.

本発明における粘着性を有する微粒子は上記測
定方法にて25℃でのボールタツク値が3〜7のも
のが用いられる。
The adhesive fine particles used in the present invention have a ball tack value of 3 to 7 at 25 DEG C. as measured by the above measuring method.

本発明におけるガラス微粒子としては、粒径
0.5mm以下の球状のものが用いられ、特に50〜
500μのものが用いられる。通常上記粘着性を有
する微粒子に対し重量比で2〜10倍のガラス微粒
子を用いる。又、粘着性を有する微粒子の表面が
ガラス微粒子で覆われ、該ガラス微粒子が連続的
に分散している様に混合せしめるのが好ましい。
The glass fine particles in the present invention have a particle size of
Spherical shapes of 0.5mm or less are used, especially 50~
500μ is used. Usually, glass particles are used in an amount of 2 to 10 times the weight of the above-mentioned adhesive particles. Further, it is preferable to mix the adhesive particles so that their surfaces are covered with glass particles and the glass particles are continuously dispersed.

上記の様にして得られた粘着性を有する微粒子
とガラス微粒子との混合物をスピツツ管の底に入
れ、次いで採血した血液を加え、血液が凝固した
後に遠心分離すれば、ガラス微粒子は比重の差に
より粘着性を有する微粒子と分離されて管の底に
沈滞し、そして粘着性を有する微粒子からなる分
離層が血清と血餅との間に形成される。尚、スピ
ツツ管に血液を入れた後に、粘着性を有する微粒
子とガラス微粒子との混合物を入れても良い。
The mixture of sticky particles and glass particles obtained as described above is placed in the bottom of a Spitz tube, then the collected blood is added, and after the blood has coagulated, the mixture is centrifuged. The serum is separated from the sticky particles and settles at the bottom of the tube, and a separation layer consisting of the sticky particles is formed between the serum and the blood clot. Note that a mixture of adhesive particles and glass particles may be added after blood is poured into the Spitz tube.

本発明の血清分離方法は、上述の様に構成され
ており、特に感圧粘着性を有する微粒子とガラス
微粒子とを共存させて遠心分離を行うので、容器
特に合成樹脂製スピツツ管内に採取した血液の凝
固が著しく促進されて短時間で血液凝固が生じ且
つ遠心分離後には血清と血餅との間に感圧粘着性
を有する微粒子同志が接合して、衝撃等により破
壊されることのない分離層が形成されるので、デ
カンテーシヨンの様な簡単な操作により血清を収
率よく採取することができる。以下、本発明を実
施例により説明する。
The serum separation method of the present invention is configured as described above, and since centrifugation is carried out by coexisting pressure-sensitive adhesive particles and glass particles, blood collected in a container, particularly a Spitz tube made of synthetic resin, is collected. The coagulation of serum and blood clots is significantly promoted and blood coagulation occurs in a short period of time, and after centrifugation, fine particles with pressure-sensitive adhesiveness bond to each other between serum and blood clots, resulting in separation that will not be destroyed by impact, etc. Since a layer is formed, serum can be collected in good yield by simple operations such as decantation. The present invention will be explained below using examples.

実施例 1 イオン交換水200重量部、ポリビニルアルコー
ル(重合度1500)0.5重量部、ブチルアクリレー
ト80重量部、スチレン15重量部、ジビニルベンゼ
ン5重量部及び過酸化ベンゾイル0.3重量部を反
応容器に投入し、窒素気流中にて80℃で10時間反
応させて、粘着性を有する微粒子の水分散液を調
整した。この分散液より微粒子を分離し、イオン
交換水で数回水洗してポリビニルアルコールを除
去した後、−50℃で凍結乾燥を行い粘着性を有す
る微粒子を得た。この微粒子の粒径は0.1〜0.5mm
であり、ボールタツク値は4であつた。
Example 1 200 parts by weight of ion-exchanged water, 0.5 parts by weight of polyvinyl alcohol (degree of polymerization 1500), 80 parts by weight of butyl acrylate, 15 parts by weight of styrene, 5 parts by weight of divinylbenzene, and 0.3 parts by weight of benzoyl peroxide were charged into a reaction vessel. The mixture was reacted at 80°C in a nitrogen stream for 10 hours to prepare an aqueous dispersion of sticky fine particles. Fine particles were separated from this dispersion, washed several times with ion-exchanged water to remove polyvinyl alcohol, and then freeze-dried at -50°C to obtain sticky fine particles. The particle size of this fine particle is 0.1~0.5mm
The ball tack value was 4.

この粘着性を有する微粒子1重量部に対し、粒
径50〜100μのガラス微粒子3重量部を添加し、
ガラス微粒子が粘着性を有する微粒子を取り囲む
ように混合した後、この混合物3gをポリスチレ
ン製スピツツ管の底に入れ、次いで採血した血液
を加えた。約40分後血液凝固が進行して血清と血
餅とに分離したので、3000rpmで5分間遠心分離
したところ、ガラス微粒子はスピツツの底に残
り、粘着性を有する微粒子は、血清と血餅の間で
この微粒子同志が接合して、分離層を形成した。
この分離層はデカンテーシヨンによつても破壊す
ることなく、スピツツ管より血清を容易に採取す
ることができた。
To 1 part by weight of this sticky fine particles, 3 parts by weight of glass fine particles with a particle size of 50 to 100μ are added,
After mixing so that the glass particles surrounded the sticky particles, 3 g of this mixture was placed at the bottom of a polystyrene Spitz tube, and then the collected blood was added. Approximately 40 minutes later, blood coagulation progressed and the blood clot separated from the serum, so when centrifuged at 3000 rpm for 5 minutes, the glass particles remained at the bottom of the spittoon, and the sticky particles separated from the serum and blood clot. The fine particles bonded to each other in between to form a separation layer.
This separation layer was not destroyed even by decantation, and serum could be easily collected from the Spitz tube.

実施例 2 イオン交換水200重量部、粒子ポリビニルアル
コール(重合度1500)0.5重量部、2―エチルヘ
キシルアクリレート70重量部、メチルメタクリレ
ート20重量部、エチレングリコールジメタクリレ
ート10重量部及び過酸化ベンゾイル0.3重量部を
反応容器に投入し、実施例1と同様に反応させた
後、分離・水洗し、−50℃で凍結乾燥させ粒径1
〜2mmの粘着性を有する微粒子を得た。
Example 2 200 parts by weight of ion-exchanged water, 0.5 parts by weight of particle polyvinyl alcohol (degree of polymerization 1500), 70 parts by weight of 2-ethylhexyl acrylate, 20 parts by weight of methyl methacrylate, 10 parts by weight of ethylene glycol dimethacrylate, and 0.3 parts by weight of benzoyl peroxide. was charged into a reaction container and reacted in the same manner as in Example 1, separated, washed with water, and freeze-dried at -50°C to obtain particles with a particle size of 1.
Microparticles with a stickiness of ~2 mm were obtained.

この微粒子のボールタツク値は4であつた。こ
の粘着性を有する微粒子1重量部に対し、粒径50
〜100μのガラス微粒子3重量部を添加し、ガラ
ス微粒子が粘着性を有する微粒子を取り囲むよう
に混合した後、この混合物3gをポリスチレン製
スピツツ管の底に入れ、次いで採血した血液を加
えた。約40分後血液凝固が進行して血清と血餅と
に分離したので、3000rpmで5分間遠心分離した
ところ、ガラス微粒子はスピツツの底に残り、粘
着性を有する微粒子は血清と血餅の間でこの微粒
子同志が接合して、分離層を形成した。この分離
層はデカンテーシヨンによつても破壊することな
く、スピツツ管より血清を容易に採取することが
できた。
The ball tack value of this fine particle was 4. For 1 part by weight of this sticky fine particle, the particle size is 50
After adding 3 parts by weight of glass particles of ~100 μm and mixing so that the glass particles surrounded the sticky particles, 3 g of this mixture was placed at the bottom of a polystyrene Spitz tube, and then the collected blood was added. After about 40 minutes, blood coagulation progressed and the blood clot was separated from the serum, so when centrifuged at 3000 rpm for 5 minutes, the glass particles remained at the bottom of the spittoon, and the sticky particles separated between the serum and blood clot. These fine particles bonded together to form a separation layer. This separation layer was not destroyed even by decantation, and serum could be easily collected from the Spitz tube.

Claims (1)

【特許請求の範囲】[Claims] 1 容器内に採取された血液を遠心分離によつて
血清と血餅とに分離する方法において、(1)比重が
1.03〜1.08、粒径が0.1〜5mmにして、25℃におけ
るボールタツク値が3〜7であり、アクリル酸エ
ステルもしくはメタクリル酸エステルのモノマー
の単独又はこれらと共重合し得るモノマーを重合
して得られる、感圧粘着性を有する微粒子1重量
部と(2)粒径50〜500μのガラス微粒子2〜10重量
部とからなる混合物を容器内の血液と共存させて
遠心分離を行うことを特徴とする血清分離方法。
1 In the method of separating blood collected in a container into serum and blood clots by centrifugation, (1)
1.03 to 1.08, the particle size is 0.1 to 5 mm, the ball tack value at 25°C is 3 to 7, and it is obtained by polymerizing an acrylic ester or methacrylic ester monomer alone or a monomer that can be copolymerized with these. , characterized in that a mixture consisting of 1 part by weight of fine particles having pressure-sensitive adhesive properties and (2) 2 to 10 parts by weight of glass fine particles with a particle size of 50 to 500 μ coexists with blood in a container and then centrifuged. Serum separation method.
JP56043588A 1981-03-24 1981-03-24 Separation of serum Granted JPS57159562A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP56043588A JPS57159562A (en) 1981-03-24 1981-03-24 Separation of serum

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56043588A JPS57159562A (en) 1981-03-24 1981-03-24 Separation of serum

Publications (2)

Publication Number Publication Date
JPS57159562A JPS57159562A (en) 1982-10-01
JPS6367659B2 true JPS6367659B2 (en) 1988-12-27

Family

ID=12667939

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56043588A Granted JPS57159562A (en) 1981-03-24 1981-03-24 Separation of serum

Country Status (1)

Country Link
JP (1) JPS57159562A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0242169A (en) * 1988-08-01 1990-02-13 Honda Motor Co Ltd engine fuel system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1041903A (en) * 1974-11-07 1978-11-07 Corning Glass Works Blood coagulation and separation
JPS52137181A (en) * 1976-05-10 1977-11-16 Terumo Corp Tube for collecting blood to separate serum or blooddplasma
JPS5328494A (en) * 1976-08-27 1978-03-16 Ajinomoto Kk Separation of serum and blood clot
JPS5751331Y2 (en) * 1977-10-03 1982-11-09
JPS55132957A (en) * 1979-04-04 1980-10-16 Ono Pharmaceut Co Ltd Blood coagulation accelerating vessel

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0242169A (en) * 1988-08-01 1990-02-13 Honda Motor Co Ltd engine fuel system

Also Published As

Publication number Publication date
JPS57159562A (en) 1982-10-01

Similar Documents

Publication Publication Date Title
KR900001380B1 (en) Processo for granulating a water-absorbent resin
US4495318A (en) Low tack microsphere glue
JP5346048B2 (en) Composite pressure-sensitive adhesive microsphere
AU628706B2 (en) Hollow acid-free acrylate polymeric microspheres having multiple small voids
TW416963B (en) Stabilized adhesive microspheres
JP5766186B2 (en) Method for producing water-absorbing polymer particles having a low tendency to solidify and a high absorption under pressure
JPH03111473A (en) Pressure sensitive adhesive agent comprising hollow adhesive microspherical body and macromonomer containing binder copolymer
JP2574410B2 (en) Spray-dried emulsion polymer, method for producing the same, and molding material containing the polymer
EP0688343A1 (en) Adhesive beads
USH509H (en) Preparation of adhesives
JPH03195713A (en) Production of polymer having high water absorption
JP3749926B2 (en) Method for producing hollow acrylate polymer microspheres
JPS6367659B2 (en)
TW200304386A (en) Compacted absorbent polymers, their production and use
JPS6367657B2 (en)
JP2885555B2 (en) Denture base resin composition
JPS6367660B2 (en)
JPS61200102A (en) Production of water-absorbing resin
CN102786635A (en) Preparation method of monodisperse large-particle size crosslinked polymethyl methacrylate (PMMA) microspheres
JP3805531B2 (en) Oil-absorbing agent comprising N-vinylcarboxylic acid amide-based crosslinked copolymer resin and method for producing the same
JP3166296B2 (en) Method for removing fine particles adhering to the surface of porous cross-linked copolymer particles
JPS6359463B2 (en)
JP2949379B2 (en) Serum separation sealant
JP2017113709A (en) Surfactant carrier
JPH02284901A (en) Production of porous polymer particles